nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—CYP3A4—Temozolomide—skin cancer	0.181	0.292	CbGbCtD
Flunisolide—CYP3A4—Imiquimod—skin cancer	0.181	0.292	CbGbCtD
Flunisolide—CYP3A4—Vismodegib—skin cancer	0.126	0.202	CbGbCtD
Flunisolide—CYP3A4—Vemurafenib—skin cancer	0.0992	0.16	CbGbCtD
Flunisolide—CYP3A4—Docetaxel—skin cancer	0.034	0.0548	CbGbCtD
Flunisolide—Fluocinonide—SMO—skin cancer	0.00688	0.837	CrCbGaD
Flunisolide—Back pain—Imiquimod—skin cancer	0.00124	0.00335	CcSEcCtD
Flunisolide—Infection—Vemurafenib—skin cancer	0.00122	0.00329	CcSEcCtD
Flunisolide—Ill-defined disorder—Imiquimod—skin cancer	0.00119	0.00321	CcSEcCtD
Flunisolide—Nausea—Vismodegib—skin cancer	0.00118	0.00318	CcSEcCtD
Flunisolide—Agitation—Imiquimod—skin cancer	0.00118	0.00318	CcSEcCtD
Flunisolide—Pneumonia—Bleomycin—skin cancer	0.00117	0.00316	CcSEcCtD
Flunisolide—Malaise—Imiquimod—skin cancer	0.00116	0.00312	CcSEcCtD
Flunisolide—Syncope—Imiquimod—skin cancer	0.00115	0.0031	CcSEcCtD
Flunisolide—Stomatitis—Bleomycin—skin cancer	0.00114	0.00307	CcSEcCtD
Flunisolide—Palpitations—Imiquimod—skin cancer	0.00113	0.00306	CcSEcCtD
Flunisolide—Loss of consciousness—Imiquimod—skin cancer	0.00113	0.00304	CcSEcCtD
Flunisolide—Irritability—Fluorouracil—skin cancer	0.00112	0.00303	CcSEcCtD
Flunisolide—Cough—Imiquimod—skin cancer	0.00112	0.00302	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00112	0.00302	CcSEcCtD
Flunisolide—Candida infection—Docetaxel—skin cancer	0.00112	0.00301	CcSEcCtD
Flunisolide—Abdominal distension—Temozolomide—skin cancer	0.00111	0.003	CcSEcCtD
Flunisolide—Hypertension—Imiquimod—skin cancer	0.00111	0.00299	CcSEcCtD
Flunisolide—Pneumonia—Dactinomycin—skin cancer	0.00109	0.00295	CcSEcCtD
Flunisolide—Chest pain—Imiquimod—skin cancer	0.00109	0.00295	CcSEcCtD
Flunisolide—Myalgia—Imiquimod—skin cancer	0.00109	0.00295	CcSEcCtD
Flunisolide—Anxiety—Imiquimod—skin cancer	0.00109	0.00294	CcSEcCtD
Flunisolide—Discomfort—Imiquimod—skin cancer	0.00108	0.00291	CcSEcCtD
Flunisolide—Decreased appetite—Vemurafenib—skin cancer	0.00107	0.00288	CcSEcCtD
Flunisolide—Bronchitis—Temozolomide—skin cancer	0.00106	0.00286	CcSEcCtD
Flunisolide—Stomatitis—Dactinomycin—skin cancer	0.00106	0.00286	CcSEcCtD
Flunisolide—Fatigue—Vemurafenib—skin cancer	0.00106	0.00286	CcSEcCtD
Flunisolide—Nasopharyngitis—Fluorouracil—skin cancer	0.00105	0.00284	CcSEcCtD
Flunisolide—Constipation—Vemurafenib—skin cancer	0.00105	0.00283	CcSEcCtD
Flunisolide—Oedema—Imiquimod—skin cancer	0.00105	0.00282	CcSEcCtD
Flunisolide—Hypoaesthesia—Bleomycin—skin cancer	0.00104	0.00281	CcSEcCtD
Flunisolide—Infection—Imiquimod—skin cancer	0.00104	0.00281	CcSEcCtD
Flunisolide—Shock—Imiquimod—skin cancer	0.00103	0.00278	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Temozolomide—skin cancer	0.00103	0.00277	CcSEcCtD
Flunisolide—Tachycardia—Imiquimod—skin cancer	0.00102	0.00276	CcSEcCtD
Flunisolide—Hyperhidrosis—Imiquimod—skin cancer	0.00101	0.00273	CcSEcCtD
Flunisolide—Weight increased—Temozolomide—skin cancer	0.001	0.00271	CcSEcCtD
Flunisolide—Pneumonia—Temozolomide—skin cancer	0.00099	0.00267	CcSEcCtD
Flunisolide—Body temperature increased—Vemurafenib—skin cancer	0.000971	0.00262	CcSEcCtD
Flunisolide—Pharyngitis—Dactinomycin—skin cancer	0.000969	0.00261	CcSEcCtD
Flunisolide—Stomatitis—Temozolomide—skin cancer	0.000959	0.00259	CcSEcCtD
Flunisolide—Urinary tract infection—Temozolomide—skin cancer	0.000957	0.00258	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000954	0.00257	CcSEcCtD
Flunisolide—Insomnia—Imiquimod—skin cancer	0.000947	0.00255	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000945	0.00255	CcSEcCtD
Flunisolide—Chills—Bleomycin—skin cancer	0.00094	0.00253	CcSEcCtD
Flunisolide—Dyspnoea—Imiquimod—skin cancer	0.000934	0.00252	CcSEcCtD
Flunisolide—Erythema multiforme—Dactinomycin—skin cancer	0.000924	0.00249	CcSEcCtD
Flunisolide—Sinusitis—Temozolomide—skin cancer	0.000923	0.00249	CcSEcCtD
Flunisolide—Dyspepsia—Imiquimod—skin cancer	0.000922	0.00249	CcSEcCtD
Flunisolide—Pneumonia—Fluorouracil—skin cancer	0.000912	0.00246	CcSEcCtD
Flunisolide—Decreased appetite—Imiquimod—skin cancer	0.00091	0.00246	CcSEcCtD
Flunisolide—Hypersensitivity—Vemurafenib—skin cancer	0.000905	0.00244	CcSEcCtD
Flunisolide—Fatigue—Imiquimod—skin cancer	0.000903	0.00244	CcSEcCtD
Flunisolide—Pain—Imiquimod—skin cancer	0.000896	0.00242	CcSEcCtD
Flunisolide—Stomatitis—Fluorouracil—skin cancer	0.000884	0.00238	CcSEcCtD
Flunisolide—Conjunctivitis—Fluorouracil—skin cancer	0.000881	0.00238	CcSEcCtD
Flunisolide—Urinary tract infection—Fluorouracil—skin cancer	0.000881	0.00238	CcSEcCtD
Flunisolide—Asthenia—Vemurafenib—skin cancer	0.000881	0.00238	CcSEcCtD
Flunisolide—Hypoaesthesia—Temozolomide—skin cancer	0.000879	0.00237	CcSEcCtD
Flunisolide—Pharyngitis—Temozolomide—skin cancer	0.000877	0.00236	CcSEcCtD
Flunisolide—Chills—Dactinomycin—skin cancer	0.000876	0.00236	CcSEcCtD
Flunisolide—Oedema peripheral—Temozolomide—skin cancer	0.00087	0.00235	CcSEcCtD
Flunisolide—Pruritus—Vemurafenib—skin cancer	0.000869	0.00234	CcSEcCtD
Flunisolide—Feeling abnormal—Imiquimod—skin cancer	0.000863	0.00233	CcSEcCtD
Flunisolide—Gastrointestinal pain—Imiquimod—skin cancer	0.000856	0.00231	CcSEcCtD
Flunisolide—Epistaxis—Fluorouracil—skin cancer	0.000855	0.00231	CcSEcCtD
Flunisolide—Sinusitis—Fluorouracil—skin cancer	0.000851	0.00229	CcSEcCtD
Flunisolide—Ill-defined disorder—Bleomycin—skin cancer	0.000846	0.00228	CcSEcCtD
Flunisolide—Diarrhoea—Vemurafenib—skin cancer	0.00084	0.00227	CcSEcCtD
Flunisolide—Migraine—Docetaxel—skin cancer	0.000836	0.00225	CcSEcCtD
Flunisolide—Erythema multiforme—Temozolomide—skin cancer	0.000835	0.00225	CcSEcCtD
Flunisolide—Urticaria—Imiquimod—skin cancer	0.000832	0.00224	CcSEcCtD
Flunisolide—Body temperature increased—Imiquimod—skin cancer	0.000828	0.00223	CcSEcCtD
Flunisolide—Abdominal pain—Imiquimod—skin cancer	0.000828	0.00223	CcSEcCtD
Flunisolide—Malaise—Bleomycin—skin cancer	0.000822	0.00222	CcSEcCtD
Flunisolide—Rhinitis—Fluorouracil—skin cancer	0.000816	0.0022	CcSEcCtD
Flunisolide—Dizziness—Vemurafenib—skin cancer	0.000812	0.00219	CcSEcCtD
Flunisolide—Hypoaesthesia—Fluorouracil—skin cancer	0.00081	0.00218	CcSEcCtD
Flunisolide—Pharyngitis—Fluorouracil—skin cancer	0.000808	0.00218	CcSEcCtD
Flunisolide—Cough—Bleomycin—skin cancer	0.000796	0.00215	CcSEcCtD
Flunisolide—Chills—Temozolomide—skin cancer	0.000793	0.00214	CcSEcCtD
Flunisolide—Ill-defined disorder—Dactinomycin—skin cancer	0.000789	0.00213	CcSEcCtD
Flunisolide—Vomiting—Vemurafenib—skin cancer	0.000781	0.00211	CcSEcCtD
Flunisolide—Chest pain—Bleomycin—skin cancer	0.000776	0.00209	CcSEcCtD
Flunisolide—Myalgia—Bleomycin—skin cancer	0.000776	0.00209	CcSEcCtD
Flunisolide—Rash—Vemurafenib—skin cancer	0.000774	0.00209	CcSEcCtD
Flunisolide—Dermatitis—Vemurafenib—skin cancer	0.000774	0.00209	CcSEcCtD
Flunisolide—Hypersensitivity—Imiquimod—skin cancer	0.000772	0.00208	CcSEcCtD
Flunisolide—Headache—Vemurafenib—skin cancer	0.000769	0.00207	CcSEcCtD
Flunisolide—Malnutrition—Temozolomide—skin cancer	0.000769	0.00207	CcSEcCtD
Flunisolide—Discomfort—Bleomycin—skin cancer	0.000767	0.00207	CcSEcCtD
Flunisolide—Malaise—Dactinomycin—skin cancer	0.000767	0.00207	CcSEcCtD
Flunisolide—Nasopharyngitis—Docetaxel—skin cancer	0.000759	0.00205	CcSEcCtD
Flunisolide—Dysgeusia—Temozolomide—skin cancer	0.000753	0.00203	CcSEcCtD
Flunisolide—Asthenia—Imiquimod—skin cancer	0.000751	0.00203	CcSEcCtD
Flunisolide—Oedema—Bleomycin—skin cancer	0.000744	0.00201	CcSEcCtD
Flunisolide—Back pain—Temozolomide—skin cancer	0.000744	0.00201	CcSEcCtD
Flunisolide—Pruritus—Imiquimod—skin cancer	0.000741	0.002	CcSEcCtD
Flunisolide—Infection—Bleomycin—skin cancer	0.000739	0.00199	CcSEcCtD
Flunisolide—Nausea—Vemurafenib—skin cancer	0.000729	0.00197	CcSEcCtD
Flunisolide—Vision blurred—Temozolomide—skin cancer	0.000725	0.00195	CcSEcCtD
Flunisolide—Myalgia—Dactinomycin—skin cancer	0.000724	0.00195	CcSEcCtD
Flunisolide—Bronchospasm—Docetaxel—skin cancer	0.000722	0.00195	CcSEcCtD
Flunisolide—Tremor—Temozolomide—skin cancer	0.000721	0.00194	CcSEcCtD
Flunisolide—Diarrhoea—Imiquimod—skin cancer	0.000717	0.00193	CcSEcCtD
Flunisolide—Discomfort—Dactinomycin—skin cancer	0.000715	0.00193	CcSEcCtD
Flunisolide—Ill-defined disorder—Temozolomide—skin cancer	0.000714	0.00192	CcSEcCtD
Flunisolide—Agitation—Temozolomide—skin cancer	0.000707	0.00191	CcSEcCtD
Flunisolide—Oedema—Dactinomycin—skin cancer	0.000694	0.00187	CcSEcCtD
Flunisolide—Malaise—Temozolomide—skin cancer	0.000694	0.00187	CcSEcCtD
Flunisolide—Dizziness—Imiquimod—skin cancer	0.000693	0.00187	CcSEcCtD
Flunisolide—Vertigo—Temozolomide—skin cancer	0.000691	0.00186	CcSEcCtD
Flunisolide—Infection—Dactinomycin—skin cancer	0.000689	0.00186	CcSEcCtD
Flunisolide—Palpitations—Temozolomide—skin cancer	0.00068	0.00183	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000678	0.00183	CcSEcCtD
Flunisolide—Cough—Temozolomide—skin cancer	0.000671	0.00181	CcSEcCtD
Flunisolide—Weight increased—Docetaxel—skin cancer	0.000668	0.0018	CcSEcCtD
Flunisolide—Vision blurred—Fluorouracil—skin cancer	0.000668	0.0018	CcSEcCtD
Flunisolide—Vomiting—Imiquimod—skin cancer	0.000666	0.0018	CcSEcCtD
Flunisolide—Hypertension—Temozolomide—skin cancer	0.000664	0.00179	CcSEcCtD
Flunisolide—Dyspnoea—Bleomycin—skin cancer	0.000663	0.00179	CcSEcCtD
Flunisolide—Rash—Imiquimod—skin cancer	0.00066	0.00178	CcSEcCtD
Flunisolide—Dermatitis—Imiquimod—skin cancer	0.00066	0.00178	CcSEcCtD
Flunisolide—Pneumonia—Docetaxel—skin cancer	0.000658	0.00178	CcSEcCtD
Flunisolide—Headache—Imiquimod—skin cancer	0.000656	0.00177	CcSEcCtD
Flunisolide—Myalgia—Temozolomide—skin cancer	0.000655	0.00177	CcSEcCtD
Flunisolide—Anxiety—Temozolomide—skin cancer	0.000652	0.00176	CcSEcCtD
Flunisolide—Discomfort—Temozolomide—skin cancer	0.000647	0.00174	CcSEcCtD
Flunisolide—Decreased appetite—Bleomycin—skin cancer	0.000647	0.00174	CcSEcCtD
Flunisolide—Stomatitis—Docetaxel—skin cancer	0.000638	0.00172	CcSEcCtD
Flunisolide—Pain—Bleomycin—skin cancer	0.000636	0.00172	CcSEcCtD
Flunisolide—Conjunctivitis—Docetaxel—skin cancer	0.000636	0.00172	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000632	0.0017	CcSEcCtD
Flunisolide—Oedema—Temozolomide—skin cancer	0.000628	0.00169	CcSEcCtD
Flunisolide—Infection—Temozolomide—skin cancer	0.000624	0.00168	CcSEcCtD
Flunisolide—Nausea—Imiquimod—skin cancer	0.000622	0.00168	CcSEcCtD
Flunisolide—Epistaxis—Docetaxel—skin cancer	0.000617	0.00166	CcSEcCtD
Flunisolide—Feeling abnormal—Bleomycin—skin cancer	0.000613	0.00165	CcSEcCtD
Flunisolide—Hyperhidrosis—Temozolomide—skin cancer	0.000607	0.00164	CcSEcCtD
Flunisolide—Chest pain—Fluorouracil—skin cancer	0.000603	0.00163	CcSEcCtD
Flunisolide—Myalgia—Fluorouracil—skin cancer	0.000603	0.00163	CcSEcCtD
Flunisolide—Decreased appetite—Dactinomycin—skin cancer	0.000603	0.00163	CcSEcCtD
Flunisolide—Fatigue—Dactinomycin—skin cancer	0.000598	0.00161	CcSEcCtD
Flunisolide—Discomfort—Fluorouracil—skin cancer	0.000596	0.00161	CcSEcCtD
Flunisolide—Pain—Dactinomycin—skin cancer	0.000593	0.0016	CcSEcCtD
Flunisolide—Urticaria—Bleomycin—skin cancer	0.000591	0.00159	CcSEcCtD
Flunisolide—Rhinitis—Docetaxel—skin cancer	0.000589	0.00159	CcSEcCtD
Flunisolide—Body temperature increased—Bleomycin—skin cancer	0.000588	0.00159	CcSEcCtD
Flunisolide—Triamcinolone—PTGS2—skin cancer	0.000585	0.0711	CrCbGaD
Flunisolide—Hypoaesthesia—Docetaxel—skin cancer	0.000585	0.00158	CcSEcCtD
Flunisolide—Pharyngitis—Docetaxel—skin cancer	0.000583	0.00157	CcSEcCtD
Flunisolide—Oedema peripheral—Docetaxel—skin cancer	0.000579	0.00156	CcSEcCtD
Flunisolide—Oedema—Fluorouracil—skin cancer	0.000578	0.00156	CcSEcCtD
Flunisolide—Infection—Fluorouracil—skin cancer	0.000575	0.00155	CcSEcCtD
Flunisolide—Feeling abnormal—Dactinomycin—skin cancer	0.000572	0.00154	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000572	0.00154	CcSEcCtD
Flunisolide—Insomnia—Temozolomide—skin cancer	0.000568	0.00153	CcSEcCtD
Flunisolide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000567	0.00153	CcSEcCtD
Flunisolide—Tachycardia—Fluorouracil—skin cancer	0.000564	0.00152	CcSEcCtD
Flunisolide—Dyspnoea—Temozolomide—skin cancer	0.00056	0.00151	CcSEcCtD
Flunisolide—Erythema multiforme—Docetaxel—skin cancer	0.000555	0.0015	CcSEcCtD
Flunisolide—Dyspepsia—Temozolomide—skin cancer	0.000552	0.00149	CcSEcCtD
Flunisolide—Body temperature increased—Dactinomycin—skin cancer	0.000549	0.00148	CcSEcCtD
Flunisolide—Abdominal pain—Dactinomycin—skin cancer	0.000549	0.00148	CcSEcCtD
Flunisolide—Hypersensitivity—Bleomycin—skin cancer	0.000548	0.00148	CcSEcCtD
Flunisolide—Decreased appetite—Temozolomide—skin cancer	0.000546	0.00147	CcSEcCtD
Flunisolide—Fatigue—Temozolomide—skin cancer	0.000541	0.00146	CcSEcCtD
Flunisolide—Pain—Temozolomide—skin cancer	0.000537	0.00145	CcSEcCtD
Flunisolide—Constipation—Temozolomide—skin cancer	0.000537	0.00145	CcSEcCtD
Flunisolide—Asthenia—Bleomycin—skin cancer	0.000534	0.00144	CcSEcCtD
Flunisolide—Chills—Docetaxel—skin cancer	0.000527	0.00142	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000527	0.00142	CcSEcCtD
Flunisolide—Pruritus—Bleomycin—skin cancer	0.000526	0.00142	CcSEcCtD
Flunisolide—Insomnia—Fluorouracil—skin cancer	0.000523	0.00141	CcSEcCtD
Flunisolide—Feeling abnormal—Temozolomide—skin cancer	0.000517	0.00139	CcSEcCtD
Flunisolide—Dyspnoea—Fluorouracil—skin cancer	0.000516	0.00139	CcSEcCtD
Flunisolide—Gastrointestinal pain—Temozolomide—skin cancer	0.000513	0.00138	CcSEcCtD
Flunisolide—Malnutrition—Docetaxel—skin cancer	0.000511	0.00138	CcSEcCtD
Flunisolide—Hypersensitivity—Dactinomycin—skin cancer	0.000511	0.00138	CcSEcCtD
Flunisolide—Dyspepsia—Fluorouracil—skin cancer	0.000509	0.00137	CcSEcCtD
Flunisolide—Decreased appetite—Fluorouracil—skin cancer	0.000503	0.00136	CcSEcCtD
Flunisolide—Dysgeusia—Docetaxel—skin cancer	0.000501	0.00135	CcSEcCtD
Flunisolide—Urticaria—Temozolomide—skin cancer	0.000499	0.00134	CcSEcCtD
Flunisolide—Asthenia—Dactinomycin—skin cancer	0.000498	0.00134	CcSEcCtD
Flunisolide—Abdominal pain—Temozolomide—skin cancer	0.000496	0.00134	CcSEcCtD
Flunisolide—Body temperature increased—Temozolomide—skin cancer	0.000496	0.00134	CcSEcCtD
Flunisolide—Back pain—Docetaxel—skin cancer	0.000495	0.00133	CcSEcCtD
Flunisolide—Pain—Fluorouracil—skin cancer	0.000495	0.00133	CcSEcCtD
Flunisolide—Betamethasone—PTGS2—skin cancer	0.000479	0.0582	CrCbGaD
Flunisolide—Feeling abnormal—Fluorouracil—skin cancer	0.000477	0.00129	CcSEcCtD
Flunisolide—Diarrhoea—Dactinomycin—skin cancer	0.000475	0.00128	CcSEcCtD
Flunisolide—Vomiting—Bleomycin—skin cancer	0.000473	0.00128	CcSEcCtD
Flunisolide—Rash—Bleomycin—skin cancer	0.000469	0.00127	CcSEcCtD
Flunisolide—Dermatitis—Bleomycin—skin cancer	0.000469	0.00126	CcSEcCtD
Flunisolide—Hypersensitivity—Temozolomide—skin cancer	0.000462	0.00125	CcSEcCtD
Flunisolide—Urticaria—Fluorouracil—skin cancer	0.000459	0.00124	CcSEcCtD
Flunisolide—Syncope—Docetaxel—skin cancer	0.000459	0.00124	CcSEcCtD
Flunisolide—Body temperature increased—Fluorouracil—skin cancer	0.000457	0.00123	CcSEcCtD
Flunisolide—Palpitations—Docetaxel—skin cancer	0.000452	0.00122	CcSEcCtD
Flunisolide—Asthenia—Temozolomide—skin cancer	0.00045	0.00121	CcSEcCtD
Flunisolide—Loss of consciousness—Docetaxel—skin cancer	0.000449	0.00121	CcSEcCtD
Flunisolide—Cough—Docetaxel—skin cancer	0.000446	0.0012	CcSEcCtD
Flunisolide—Pruritus—Temozolomide—skin cancer	0.000444	0.0012	CcSEcCtD
Flunisolide—Nausea—Bleomycin—skin cancer	0.000442	0.00119	CcSEcCtD
Flunisolide—Hypertension—Docetaxel—skin cancer	0.000442	0.00119	CcSEcCtD
Flunisolide—Vomiting—Dactinomycin—skin cancer	0.000441	0.00119	CcSEcCtD
Flunisolide—Rash—Dactinomycin—skin cancer	0.000438	0.00118	CcSEcCtD
Flunisolide—Myalgia—Docetaxel—skin cancer	0.000435	0.00117	CcSEcCtD
Flunisolide—Chest pain—Docetaxel—skin cancer	0.000435	0.00117	CcSEcCtD
Flunisolide—Diarrhoea—Temozolomide—skin cancer	0.000429	0.00116	CcSEcCtD
Flunisolide—Hypersensitivity—Fluorouracil—skin cancer	0.000426	0.00115	CcSEcCtD
Flunisolide—Oedema—Docetaxel—skin cancer	0.000417	0.00113	CcSEcCtD
Flunisolide—Dizziness—Temozolomide—skin cancer	0.000415	0.00112	CcSEcCtD
Flunisolide—Infection—Docetaxel—skin cancer	0.000415	0.00112	CcSEcCtD
Flunisolide—Nausea—Dactinomycin—skin cancer	0.000412	0.00111	CcSEcCtD
Flunisolide—Shock—Docetaxel—skin cancer	0.000411	0.00111	CcSEcCtD
Flunisolide—Pruritus—Fluorouracil—skin cancer	0.000409	0.0011	CcSEcCtD
Flunisolide—Tachycardia—Docetaxel—skin cancer	0.000407	0.0011	CcSEcCtD
Flunisolide—Vomiting—Temozolomide—skin cancer	0.000399	0.00108	CcSEcCtD
Flunisolide—Rash—Temozolomide—skin cancer	0.000396	0.00107	CcSEcCtD
Flunisolide—Diarrhoea—Fluorouracil—skin cancer	0.000396	0.00107	CcSEcCtD
Flunisolide—Dermatitis—Temozolomide—skin cancer	0.000395	0.00107	CcSEcCtD
Flunisolide—Headache—Temozolomide—skin cancer	0.000393	0.00106	CcSEcCtD
Flunisolide—Dizziness—Fluorouracil—skin cancer	0.000382	0.00103	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00038	0.00103	CcSEcCtD
Flunisolide—Insomnia—Docetaxel—skin cancer	0.000378	0.00102	CcSEcCtD
Flunisolide—Nausea—Temozolomide—skin cancer	0.000373	0.00101	CcSEcCtD
Flunisolide—Dyspnoea—Docetaxel—skin cancer	0.000372	0.001	CcSEcCtD
Flunisolide—Vomiting—Fluorouracil—skin cancer	0.000368	0.000992	CcSEcCtD
Flunisolide—Dyspepsia—Docetaxel—skin cancer	0.000367	0.000991	CcSEcCtD
Flunisolide—Rash—Fluorouracil—skin cancer	0.000365	0.000983	CcSEcCtD
Flunisolide—Dermatitis—Fluorouracil—skin cancer	0.000364	0.000982	CcSEcCtD
Flunisolide—Decreased appetite—Docetaxel—skin cancer	0.000363	0.000978	CcSEcCtD
Flunisolide—Headache—Fluorouracil—skin cancer	0.000362	0.000977	CcSEcCtD
Flunisolide—Fatigue—Docetaxel—skin cancer	0.00036	0.00097	CcSEcCtD
Flunisolide—Pain—Docetaxel—skin cancer	0.000357	0.000963	CcSEcCtD
Flunisolide—Constipation—Docetaxel—skin cancer	0.000357	0.000963	CcSEcCtD
Flunisolide—Feeling abnormal—Docetaxel—skin cancer	0.000344	0.000928	CcSEcCtD
Flunisolide—Nausea—Fluorouracil—skin cancer	0.000343	0.000926	CcSEcCtD
Flunisolide—Gastrointestinal pain—Docetaxel—skin cancer	0.000341	0.00092	CcSEcCtD
Flunisolide—Body temperature increased—Docetaxel—skin cancer	0.00033	0.00089	CcSEcCtD
Flunisolide—Abdominal pain—Docetaxel—skin cancer	0.00033	0.00089	CcSEcCtD
Flunisolide—Hypersensitivity—Docetaxel—skin cancer	0.000308	0.000829	CcSEcCtD
Flunisolide—Asthenia—Docetaxel—skin cancer	0.000299	0.000808	CcSEcCtD
Flunisolide—Pruritus—Docetaxel—skin cancer	0.000295	0.000796	CcSEcCtD
Flunisolide—Diarrhoea—Docetaxel—skin cancer	0.000286	0.00077	CcSEcCtD
Flunisolide—Dexamethasone—PTGS2—skin cancer	0.000279	0.0339	CrCbGaD
Flunisolide—Dizziness—Docetaxel—skin cancer	0.000276	0.000744	CcSEcCtD
Flunisolide—Vomiting—Docetaxel—skin cancer	0.000265	0.000716	CcSEcCtD
Flunisolide—Rash—Docetaxel—skin cancer	0.000263	0.00071	CcSEcCtD
Flunisolide—Dermatitis—Docetaxel—skin cancer	0.000263	0.000709	CcSEcCtD
Flunisolide—Headache—Docetaxel—skin cancer	0.000261	0.000705	CcSEcCtD
Flunisolide—Nausea—Docetaxel—skin cancer	0.000248	0.000669	CcSEcCtD
